| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0067 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.0067 | 0.8 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.8 |
| mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.007 | 0.8 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.03 | 0.8 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |